You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

oligodendroglioma

Showing 1 - 25 of 387
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oligodendroglioma, Adult Trial in Philadelphia (Abemaciclib 200 MG)

Active, not recruiting
  • Oligodendroglioma, Adult
  • Abemaciclib 200 MG
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Sep 6, 2022

Newly Oligodendroglioma Towards Secondary Glioma

Enrolling by invitation
  • Oligodendroglioma, Adult
  • Stressors
  • (no location specified)
Sep 8, 2022

Oligodendroglioma Trial in Zhengzhou (Tislelizumab plus Bevacizumab)

Recruiting
  • Oligodendroglioma
  • Tislelizumab plus Bevacizumab
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Aug 21, 2022

Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)

Recruiting
  • Glioblastoma
  • +3 more
  • Adaptive Radiotherapy
  • New York, New York
    Columbia University Irving Medical Center
Oct 27, 2023

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

Not yet recruiting
  • Anaplastic Astrocytoma
  • +17 more
    • (no location specified)
    Jun 28, 2023

    AI R&D Tool in Adult Glioma and Other Primary Brain Tumours

    Not yet recruiting
    • Brain Tumor
    • +4 more
    • Resection
    • London, United Kingdom
      Imperial College Healthcare NHS Trust
    Sep 15, 2023

    Astrocytoma, Glioblastoma, Oligodendroglioma Trial in Atlanta (Craniotomy, Quantitative Oblique Back-Illumination Microscopy)

    Not yet recruiting
    • Astrocytoma
    • +2 more
    • Craniotomy
    • Quantitative Oblique Back-Illumination Microscopy
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Aug 22, 2022

    Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

    Not yet recruiting
    • Recurrent High Grade Glioma
    • +4 more
    • (no location specified)
    Jan 24, 2023

    Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)

    Not yet recruiting
    • Glioblastoma Multiforme
    • +4 more
    • SIACI of cetuximab and bevacizumab
    • Miami, Florida
      Jackson Memorial Hospital
    Jul 14, 2023

    Adult Diffuse Glioma Based on Deep Learning

    Recruiting
    • Astrocytoma
    • +2 more
    • multi-parametric magnetic resonance imaging scan
    • Pathology examination
    • Nanjing, Jiangsu, China
      Department of Radiology, the Affiliated Drum Tower Hospital of N
    Nov 21, 2022

    Glioblastoma, Astrocytoma, Oligodendroglioma Trial (OKN-007)

    Withdrawn
    • Glioblastoma
    • +2 more
    • (no location specified)
    Oct 5, 2022

    Astrocytoma, Oligodendroglioma, Adult, Glioma, Malignant Trial in Saint Louis (temporally-modulated pulsed radiotherapy (TMPRT))

    Recruiting
    • Astrocytoma
    • +2 more
    • temporally-modulated pulsed radiotherapy (TMPRT)
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 19, 2023

    Recurrent Glioblastoma, Recurrent Astrocytoma, Recurrent Oligodendroglioma Trial in Oklahoma City (Niraparib)

    Recruiting
    • Recurrent Glioblastoma
    • +3 more
    • Oklahoma City, Oklahoma
      Stephenson Cancer Center
    Jul 20, 2022

    Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

    Completed
    Has Results
    • Glioma
    • +7 more
    • Neural stem cells loaded with an oncolytic adenovirus
    • Duarte, California
    • +1 more
    Dec 28, 2022

    Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

    Recruiting
    • Anaplastic Astrocytoma, IDH-Wildtype
    • +8 more
    • Quality-of-Life Assessment
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 8, 2022

    High-grade Glioma, Oligodendroglioma, Astrocytoma Trial (Low-dose OKN-007, BID, Low-dose OKN-007, TID, Mid-dose OKN-007, TID)

    Not yet recruiting
    • High-grade Glioma
    • +3 more
    • Low-dose OKN-007, BID
    • +3 more
    • (no location specified)
    Sep 26, 2022

    Glioma, IDH Mutation, Astrocytoma Trial in Philadelphia (Retifanlimab, All-trans retinoic acid)

    Not yet recruiting
    • Glioma
    • +3 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jul 22, 2022

    Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after

    Active, not recruiting
    • Oligodendroglioma
    • +5 more
    • GBM6-AD and poly-ICLC before and after surgery
    • GBM6-AD and poly-ICLC after surgery only
    • San Francisco, California
      University of California
    Sep 20, 2022

    Recurrent High-grade Glioma, Recurrent Glioblastoma, Recurrent Anaplastic Astrocytoma Trial in Incheon (500mg/kg/3hr followed by

    Recruiting
    • Recurrent High-grade Glioma
    • +3 more
    • 500mg/kg/3hr followed by neutron irradiation to reach maximum brain dose of 9Gy-Eq
    • +2 more
    • Incheon, Korea, Republic of
      Gachon University Gil Medical Center
    Feb 19, 2023

    Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma Trial in New York (Cytoreductive surgery, Perifosine, Temsirolimus)

    Active, not recruiting
    • Brain Tumor, Recurrent
    • +4 more
    • Cytoreductive surgery
    • +2 more
    • New York, New York
    • +1 more
    Jun 9, 2022

    Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

    Withdrawn
    • Recurrent Anaplastic Astrocytoma
    • +7 more
    • Neural Stem Cells-expressing CRAd-S-pk7
    • Resection
    • (no location specified)
    Nov 22, 2022

    Oligodendroglioma, Oligodendroglioma, Anaplastic, Diffuse Astrocytoma, IDH-Mutant Trial in Oslo (Radiation therapy)

    Recruiting
    • Oligodendroglioma
    • +2 more
    • Radiation therapy
    • Oslo, Norway
      Oslo University Hospital
    Jan 14, 2022

    CNS Cancer, CNS BRAIN Trial in Basking Ridge, Commack, New York (temozolomide followed by high dose busulfan and thiotepa)

    Active, not recruiting
    • CNS Cancer
    • CNS BRAIN
    • temozolomide followed by high dose busulfan and thiotepa
    • Basking Ridge, New Jersey
    • +2 more
    Oct 7, 2021

    Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute

    Recruiting
    • Astrocytoma, Grades II, III and IV
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 31, 2023

    Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester

    Active, not recruiting
    • Childhood Astrocytoma
    • +9 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic
    Sep 8, 2022